Bortezomib, adriamycin dexamethasone (PAD) combination therapies or patients with relapsed or refractory myeloma previously treated with VAD or VAD like therapy.

Michael O'Dwyer

Bortezomib, adriamycin dexamethasone (PAD) combination therapies or patients with relapsed or refractory myeloma previously treated with VAD or VAD like therapy.

Medicine

Research output: Other contribution (Published) › Other contribution

Original language	English (Ireland)
Media of output	Meeting
Volume	108
Publication status	Published - 1 Nov 2006

Cite this

@misc{7ef830e8f6634a13a53bc57e197a8f2b,

title = "Bortezomib, adriamycin dexamethasone (PAD) combination therapies or patients with relapsed or refractory myeloma previously treated with VAD or VAD like therapy.",

author = "Michael O'Dwyer",

year = "2006",

month = nov,

day = "1",

language = "English (Ireland)",

volume = "108",

type = "Other",

}